- Betschart P, Zumstein V, Piller A, Schmid HP, Abt D. Prevention and treatment of symptoms associated with indwelling ureteral stents: a systematic review. Int J Urol. 2017;24(4):250–259. doi:10.1111/iju.13311.
- Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 2003;169(3):1065–1069. doi:10.1097/01.ju.0000048980.33855.90.
- Dellis AE, Papatsoris AG, Keeley FX, Jr, Bamias A, Deliveliotis C, Skolarikos AA. Tamsulosin, solifenacin, and their combination for the treatment of stent-related symptoms: a randomized controlled study. J Endourol. 2017;31(1):100–109. doi:10.1089/end.2016.0663.
- Liu Q, Liao B, Zhang R. Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms—outcome from a randomized controlled trial. BMC Urol. 2016;16:66.
- Park J, Yoo C, Han DH, Shin DW. A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 x 2 factorial randomized trial. World J Urol. 2015;33(11):1833–1840. doi:10.1007/s00345-015-1544-1.
- Ragab M, Soliman MG, Tawfik A, et al. The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial. Int Urol Nephrol. 2017;49(6):961–966. doi:10.1007/s11255-017-1561-7.
- Wang J, Zhang X, Zhang T, Mu J, Bai B, Lei Y. The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis. World J Urol. 2017;35(11):1669–1680. doi:10.1007/s00345-017-2051-3.
- Moradi M, Abdi H, Ebrahimi S, Rezaee H, Kaseb K. Effects of tamsulosin and tolterodine on double J stent-related symptoms: a double-blind, randomized, placebo-controlled trial. SAGE Open Med. 2017;5:205031211769643. doi:10.1177/2050312117696436.
- Zhang L, Li J, Pan M, Han W, Liu S, Xiao Y. Doxazosin oral intake therapy to relieve stent-related urinary symptoms and pain: a prospective, randomized, controlled study. Int Braz J Urol. 2016;42(4):727–733. doi:10.1590/S1677-5538.IBJU.2015.0570.
- Singh I, Tripathy S, Agrawal V. Efficacy of tamsulosin hydrochloride in relieving “double-J ureteral stent-related morbidity”: a randomized placebo controlled clinical study. Int Urol Nephrol. 2014;46(12):2279–2283. doi:10.1007/s11255-014-0825-8.
- Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ. Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort. BJU Int. 2011;108(11):1894–1902. doi:10.1111/j.1464-410X.2011.10170.x.
- Lee FC, Holt SK, Hsi RS, Haynes BM, Harper JD. Preoperative belladonna and opium suppository for ureteral stent pain: a randomized, double-blinded, placebo-controlled study. Urology. 2017;100:27–32. doi:10.1016/j.urology.2016.07.035.
- Nazim SM, Ather MH. Alpha-blockers impact stent-related symptoms: a randomized, double-blind, placebo-controlled trial. J Endourol. 2012;26(9):1237–1241. doi:10.1089/end.2012.0036.
- Denstedt J, Wollin T, Sofer M, Nott L, Weir M, Honey R. A prospective randomized controlled trial comparing nonstented versus stented ureteroscopic lithotripsy. J Urol. 2001;165(5):1419–1422. doi:10.1016/S0022-5347(05)66320-3.
- Chen YT, Chen J, Wong WY, Yang SS, Hsieh CH, Wang CC. Is ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy? A prospective, randomized controlled trial. J Urol. 2002;167(5):1977–1980.
- Pais VM, Jr, Smith RE, Stedina EA, Rissman CM. Does omission of ureteral stents increase risk of unplanned return visit? A systematic review and meta-analysis. J Urol. 2016;196(5):1458–1466. doi:10.1016/j.juro.2016.05.109.
- Muslumanoglu AY, Fuglsig S, Frattini A, et al. Risks and benefits of postoperative DoubleJ Stent placement after ureteroscopy: results from the Clinical Research Office of Endourological Society Ureteroscopy Global Study. J Endourol. 2017;31(5):446–451. doi:10.1089/end.2016.0827.
- Wang H, Man L, Li G, Huang G, Liu N, Wang J. Meta-analysis of stenting versus non-stenting for the treatment of ureteral stones. PLoS One. 2017;12(1):e0167670. doi:10.1371/journal.pone.0167670.
- Centers for Disease Control and Prevention. Wide-Ranging Online Data for Epidemiologic Research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2017.
- Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–1452. doi:10.15585/mmwr.mm655051e1.
- Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–1645. doi:10.1001/jama.2016.1464.
- Frieden TR, Houry D. Reducing the risks of relief—the cdc opioid-prescribing guideline. N Engl J Med. 2016;374(16):1501–1504. doi:10.1056/NEJMp1515917.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 2
Original Research
Relation of postoperative pain medication to return for unplanned care after ureteroscopy
, MD, 
, , MD, & , MD
Kim H. ThaiDivision of Urology, Department of Surgery, Scott & White Medical Center–Temple, Temple, TexasCorrespondence[email protected]
http://orcid.org/0000-0002-6007-6352
, MD http://orcid.org/0000-0002-6007-6352, , MD, Patrick S. LowryDivision of Urology, Department of Surgery, Scott & White Medical Center–Temple, Temple, Texashttp://orcid.org/0000-0003-0806-7413
, MD http://orcid.org/0000-0003-0806-7413 & , MD